Inogen/$INGN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Inogen
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
Ticker
$INGN
Sector
Primary listing
Industry
Health Care Equipment and Supplies
Headquarters
Employees
766
Website
Inogen Metrics
BasicAdvanced
$170M
-
-$1.15
1.64
-
Price and volume
Market cap
$170M
Beta
1.64
52-week high
$12.91
52-week low
$5.70
Average daily volume
192K
Financial strength
Current ratio
3.067
Quick ratio
2.376
Long term debt to equity
8.218
Total debt to equity
9.705
Profitability
EBITDA (TTM)
-9.994
Gross margin (TTM)
46.11%
Net profit margin (TTM)
-8.08%
Operating margin (TTM)
-9.10%
Effective tax rate (TTM)
1.91%
Revenue per employee (TTM)
$440,000
Management effectiveness
Return on assets (TTM)
-6.19%
Return on equity (TTM)
-14.10%
Valuation
Price to revenue (TTM)
0.447
Price to book
0.86
Price to tangible book (TTM)
1.08
Price to free cash flow (TTM)
-7.196
Free cash flow yield (TTM)
-13.90%
Free cash flow per share (TTM)
-0.877
Growth
Revenue change (TTM)
5.73%
Earnings per share change (TTM)
-72.29%
3-year revenue growth (CAGR)
-1.10%
10-year revenue growth (CAGR)
10.73%
3-year earnings per share growth (CAGR)
9.55%
10-year earnings per share growth (CAGR)
12.99%
What the Analysts think about Inogen
Analyst ratings (Buy, Hold, Sell) for Inogen stock.
Inogen Financial Performance
Revenues and expenses
Inogen Earnings Performance
Company profitability
Inogen News
AllArticlesVideos
Inogen to Report Second Quarter 2025 Financial Results on August 7, 2025
Business Wire·2 weeks ago
Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy
Business Wire·1 month ago
Inogen Upgraded: Analyst Sees Growth, EBITDA Breakthrough
Benzinga·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Inogen stock?
Inogen (INGN) has a market cap of $170M as of August 01, 2025.
What is the P/E ratio for Inogen stock?
The price to earnings (P/E) ratio for Inogen (INGN) stock is 0 as of August 01, 2025.
Does Inogen stock pay dividends?
No, Inogen (INGN) stock does not pay dividends to its shareholders as of August 01, 2025.
When is the next Inogen dividend payment date?
Inogen (INGN) stock does not pay dividends to its shareholders.
What is the beta indicator for Inogen?
Inogen (INGN) has a beta rating of 1.64. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.